Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

• Main Authors: Januszewski, Andrzej S., Chen, David, Scott, Russell S., O'Connell, Rachel L., Aryal, Nanda R., Sullivan, David R., Watts, Gerald F., Taskinen, Marja-Riitta, Barter, Philip J., Best, James D., Simes, John R., Keech, Anthony C., Jenkins, Alicia J.
• 其他作者: Lee Kong Chian School of Medicine (LKCMedicine)
• 格式: Article
• 語言: English
• 出版: 2021
• 主題: Science::Medicine; Diabetes; Endocrinology
• 在線閱讀: https://hdl.handle.net/10356/153807

People with diabetes are at risk of chronic complications and novel biomarkers, such as Advanced glycation end-products (AGEs) may help stratify this risk. We assessed whether plasma low-molecular weight AGEs, also known as LMW-fluorophores (LMW-F), are associated with risk factors, predict complica...